申请人:Alexander Rikki Peter
公开号:US20100298310A1
公开(公告)日:2010-11-25
A series of thiazole derivatives which are substituted in the 2-position by a substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
一系列噻唑衍生物,在2-位置被取代的吗啉-4-基团选择性地抑制PI3激酶酶,因此在医学上具有益处,例如在炎症,自身免疫,心血管,神经退行性,代谢,肿瘤,疼痛或眼科疾病的治疗中。